Sutton Wealth Advisors Inc. Nektar Therapeutics Transaction History

Sutton Wealth Advisors Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2023	SELL	$3.04 - $5.14 $9,013 - $15,240	-2,965 Reduced 94.04%	188 $602,000
Q1 2022 Nov 07, 2023	BUY	$4.16 - $13.72 $10,591 - $34,931	2,546 Added 419.44%	3,153 $17 Million
Q4 2021 Nov 07, 2023	BUY	$10.83 - $18.41 $498 - $846	46 Added 8.2%	607 $8.2 Million
Q1 2020 Nov 07, 2023	BUY	$14.47 - $27.96 $8,117 - $15,685	561 New	561 $10 Million
Q4 2019 Nov 07, 2023	SELL	$15.87 - $23.12 $0 - $0	0 Closed	0 $0

Q3 2019 Nov 07, 2023	SELL	$16.91 - $36.27 $202 - $435	-12 Closed	0 $0
Q2 2019 Nov 06, 2023	SELL	$31.0 - $36.3 $558 - $653	-18 Reduced 60.0%	12 $427,000
Q4 2018 Nov 06, 2023	SELL	$30.43 - $56.65 $3,469 - $6,458	-114 Reduced 79.17%	30 $986,000
Q3 2018 Nov 06, 2023	SELL	$46.46 - $68.49 $12,497 - $18,423	-269 Reduced 65.13%	144 $8.78 Million
Q2 2018 Nov 06, 2023	BUY	$46.25 - $104.45 $7,955 - $17,965	172 Added 71.37%	413 $20.2 Million
Q1 2018 Nov 06, 2023	SELL	$57.4 - $108.44 $119,105 - $225,013	-2,075 Reduced 89.59%	241 $25.6 Million
Q4 2017 Nov 06, 2023	BUY	$23.02 - $60.5 $9,737 - $25,591	423 Added 22.35%	2,316 $138 Million
Q3 2017 Nov 06, 2023	SELL	$17.79 - $24.0 $3,718 - $5,016	-209 Reduced 9.94%	1,893 $45.4 Million
Q2 2017 Nov 06, 2023	BUY	N/A	34 Added 1.64%	2,102 $41.1 Million
Q1 2017 Nov 06, 2023	BUY	N/A	509 Added 32.65%	2,068 $48.5 Million
Q1 2016 Nov 06, 2023	BUY	N/A	1,559	1,559 $21.4 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.